Immediate Impact
54 standout
Citing Papers
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
2024 Standout
Works of Maureen Thompson being referenced
Risks Associated With Lentiviral Vector Exposures and Prevention Strategies
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Maureen Thompson | 112 | 156 | 50 | 199 | 163 | 24 | 646 | |
| Tong Yang | 109 | 133 | 23 | 256 | 66 | 37 | 593 | |
| Sarah J. White | 99 | 27 | 13 | 110 | 49 | 57 | 538 | |
| Anke Oerlemans | 112 | 48 | 7 | 61 | 42 | 50 | 596 | |
| Elaine K. Daily | 44 | 235 | 3 | 101 | 139 | 28 | 684 | |
| Anthony C. Antonacci | 30 | 78 | 33 | 28 | 54 | 39 | 559 | |
| Kevin Shi | 79 | 174 | 22 | 18 | 101 | 24 | 566 | |
| Shlomo Mor‐Yosef | 88 | 51 | 8 | 47 | 35 | 32 | 571 | |
| Lucy M. Osborn | 210 | 42 | 18 | 97 | 32 | 31 | 615 | |
| Arthur S. Banner | 80 | 27 | 8 | 280 | 39 | 25 | 736 | |
| C Jamieson | 30 | 52 | 47 | 64 | 34 | 32 | 655 |
All Works
Loading papers...